Module 9 2024

03/09/2024

Glossary (1)

CMV

Cytomegalovirus

CPP

Certificate of Pharmaceutical Product

DTPa

Diphtheria-Tetanus-acellular Pertussis

EMP

Essential medicines and health products

EPI

Extended Programme on Immunisation

FTIH

First Time In Humans

HBS

Hepatitis B Surface antigen

HBV

Hepatitis B Vaccine

HCV

Hepatitis C Vaccine

Hib-MenC

Haemophilus influenzae b – Meningococcal Group C

HIV

Human Immunodeficiency Virus

HIS

Health Systems and Innovation (WHO)

HPV

Human Papilloma Virus

IPV

Inactivated Polio Vaccine

OPV

Oral Polio Vaccine

MMRV

Measles Mumps Rubella Varicella

The Organisation for Professionals in Regulatory Affairs

95

Glossary (2)

NCL

National Control Laboratory

NRA

National Regulatory Authority

MPL

Monophospholipid

OMCL

Official Medicines Control Laboratory

UN

United Nations

UNICEF

United Nations International Children's Emergency Fund

PAHO

Pan-American Health Organisation

PMS

Post-Marketing Surveillance

PQ

Prequalification

PQT

Prequalification Team (WHO)

QS-21

Saponin extracted from the bark of the Quillaja saponaria tree

RHT

Regulation of medicines and other Health Technologies (Regulatory Dept. at WHO)

mRNA

Messenger Ribose Nucleic Acid (vaccines)

RSV

Respiratory Syncytial Virus

PSPQ

Programmatic Suitability for Prequalification

WHO

World Health Organisation

UMV

Universal Mass Vaccination

Vx

Vaccine

The Organisation for Professionals in Regulatory Affairs

96

48